Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00228540
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2005-09-27
Brief Title:
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Study Overview
Official Title:
An 8 Week Open-Label Study to Characterize the Response to Modafinil 85 mg Film Coated Tablet Treatment at Dosages Up to 425 mgDay in Children and Adolescents With Attention DeficitHyperactivity Disorder ADHD With an Open Ended Extension Period
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An 8-week Open-Label Study to Characterize the Response to Modafinil 85mg Film-Coated Tablet Treatment at Dosages up to 425mgDay in Children and Adolescents with Attention-DeficitHyperactivity Disorder ADHD With an Open-Ended Extension Period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None